Sheep Spleen Extract (Ovis aries)

Sheep spleen extract (Ovis aries) is a glandular supplement derived from ovine splenic tissue, theorized to contain bioactive peptides, splenopentin analogs, and tuftsin — a tetrapeptide produced in the spleen. No human clinical trials have validated its therapeutic use, and current evidence is limited to veterinary anatomical and morphological studies.

Origin & History

Sheep Spleen Extract is derived from the spleen of Ovis aries (domestic sheep), a triangular organ averaging 39.6g in weight located in the abdominal cavity. The spleen consists of red pulp (containing erythrocytes, lymphocytes, and macrophages) and white pulp (lymphoid follicles), though specific extraction methods and standardization processes are not documented in available research.

Historical & Cultural Context

No historical or traditional medicinal uses in any cultural systems are documented in the available research. All sources are limited to modern veterinary anatomy and histology studies without reference to traditional applications.

Health Benefits

• No clinically proven health benefits - no human clinical trials exist
• No evidence for immune support - only anatomical studies available
• No documented effects on blood health - research limited to veterinary morphology
• No verified anti-inflammatory properties - no biochemical mechanism studies found
• No established benefits for any health condition - all available research focuses on sheep anatomy only

How It Works

Sheep spleen extract is hypothesized to deliver tuftsin (Thr-Lys-Pro-Arg), a tetrapeptide that binds to receptors on macrophages and neutrophils to stimulate phagocytosis, though this mechanism has only been studied in isolated bovine and murine models, not ovine-derived oral supplements. Splenopentin, a five-amino-acid fragment of spleen-derived proteins, has been theorized to modulate T-lymphocyte activity via interactions with immunoregulatory pathways in animal studies. No receptor-binding or enzyme-level data currently exists specifically for orally administered Ovis aries spleen extract, as gastric proteolysis likely degrades these peptides before systemic absorption occurs.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses examining Sheep Spleen Extract were identified in the research. Available studies focus exclusively on veterinary anatomy and sheep organ morphology (n=30 adult cadavers for gross morphology, n=18 fetuses for developmental studies), with no PMIDs for clinical outcomes in humans.

Clinical Summary

There are zero published human clinical trials investigating sheep spleen extract as a dietary supplement for any health indication. The available literature consists exclusively of veterinary morphological studies examining ovine spleen architecture, cell populations, and comparative anatomy across livestock breeds. Research on structurally similar compounds — such as tuftsin isolated from human splenic tissue — dates to Najjar et al. (1970s) and was conducted in vitro and in rodent models, providing no direct translatable evidence for commercial sheep spleen supplements. The overall evidence base must be characterized as absent, and any marketed health claims for this ingredient currently lack scientific substantiation.

Nutritional Profile

Sheep spleen extract derived from Ovis aries is a protein-rich tissue extract. Based on mammalian spleen composition data (direct sheep-specific concentration data is sparse in human nutrition literature): Protein content is estimated at 16-18g per 100g fresh weight, comprising primarily hemoglobin-associated proteins, albumin, globulins, and structural proteins such as collagen and actin. Iron is a notable micronutrient given the spleen's role as a blood reservoir and erythrocyte recycling organ — heme iron concentration is estimated at 8-15mg per 100g fresh tissue, with heme iron bioavailability of approximately 15-35% (superior to non-heme iron sources). Zinc is present at approximately 2-4mg per 100g. Vitamin B12 is expected at 2-5µg per 100g based on comparable bovine spleen data. Copper, associated with ceruloplasmin and hemosiderin storage, is estimated at 0.3-0.8mg per 100g. The extract likely contains immunoglobulins, tuftsin (a spleen-derived tetrapeptide: Thr-Lys-Pro-Arg) known from bovine and porcine sources, and splenopentin (an immunomodulatory pentapeptide documented in mammalian spleens generally). Fat content is low, estimated at 3-5g per 100g, with negligible carbohydrate content. Bioavailability of extracted proteins depends heavily on processing method (hydrolyzed extracts improve peptide absorption); no sheep-specific bioavailability studies are currently published.

Preparation & Dosage

No clinically studied dosage ranges, standardized forms, or preparation methods have been established for human consumption. No safety data, maximum doses, or administration guidelines are available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified due to lack of mechanism studies

Safety & Interactions

Sheep spleen extract carries a theoretical risk of prion-related contamination given its origin from neural-adjacent lymphoid tissue, though no confirmed cases from commercially processed supplements have been documented in the literature. Individuals with red meat allergies or alpha-gal syndrome (sensitization to galactose-alpha-1,3-galactose, a carbohydrate found in mammalian tissues) should avoid this supplement due to potential cross-reactivity. No formal drug interaction studies exist, but caution is advised alongside immunosuppressant medications such as cyclosporine or corticosteroids, as hypothesized immune-modulatory peptides could theoretically antagonize these therapies. Pregnant or breastfeeding individuals should avoid use entirely due to complete absence of safety data in these populations.